Cardiac consequences of hypertension in hemodialysis patients

Semin Dial. Jul-Aug 2004;17(4):299-303. doi: 10.1111/j.0894-0959.2004.17331.x.


Hypertension in end-stage renal disease (ESRD) is an important risk factor for left ventricular hypertrophy (LVH), cardiac failure, coronary artery disease (CAD), and arrhythmia. LVH is generally considered an integrator of the long-term effects of hypertension and other cardiovascular (CV) risk factors and represents the strongest predictor of adverse CV outcomes in ESRD patients. The risk of heart failure is higher in patients with a history of hypertensive renal disease than in those with other diagnoses. Both coronary heart disease (CHD) and LVH predict congestive heart failure, which is often the ultimate cause of death in patients with cardiac ischemia or LVH. A history of long-standing hypertension is associated with ischemic heart disease both in cross-sectional and prospective studies in ESRD. Atrial fibrillation and ventricular arrhythmias are highly prevalent in dialysis patients and are implicated in mortality and sudden death in this population. Despite the lack of evidence from randomized controlled trials, it appears reasonable that interventions aimed at curbing the high CV mortality of ESRD should be targeted to both hypertension and LVH.

Publication types

  • Review

MeSH terms

  • Arrhythmias, Cardiac / etiology
  • Arrhythmias, Cardiac / physiopathology
  • Coronary Disease / etiology
  • Coronary Disease / physiopathology
  • Heart Diseases / etiology*
  • Heart Failure / etiology
  • Heart Failure / physiopathology
  • Humans
  • Hypertension / complications*
  • Hypertension / physiopathology
  • Hypertrophy, Left Ventricular / etiology
  • Hypertrophy, Left Ventricular / physiopathology
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / physiopathology
  • Renal Dialysis*